MARKET WIRE NEWS

MaxCyte, Inc. (MXCT) Q2 2025 Earnings Call Transcript

Source: SeekingAlpha

2025-08-07 03:45:29 ET

MaxCyte, Inc. (MXCT)

Q2 2025 Earnings Conference Call

August 06, 2025, 04:30 PM ET

Company Participants

Douglas J. Swirsky - Chief Financial Officer

Maher Masoud - President, CEO & Executive Director

Conference Call Participants

Brendan Mychal Smith - TD Cowen, Research Division

Hannah Webb Hefley - Stephens Inc., Research Division

Matthew Richard Larew - William Blair & Company L.L.C., Research Division

Rohan Walcott - Unidentified Company

Stifel - Unidentified Company

Presentation

Operator

Good day, and thank you for standing by. Welcome to the MaxCyte Second Quarter Earnings Conference Call. [Operator Instructions] Today's conference is being recorded.

I would now like to hand the conference over to your first speaker today, [ Eric Abdal ], Investor Relations. Please go ahead....

Read the full article on Seeking Alpha

For further details see:

MaxCyte, Inc. (MXCT) Q2 2025 Earnings Call Transcript
MaxCyte Inc.

NASDAQ: MXCT

MXCT Trading

5.77% G/L:

$1.10 Last:

1,382,133 Volume:

$1.04 Open:

mwn-ir Ad 300

MXCT Latest News

MXCT Stock Data

$82,138,988
103,153,769
1.05%
195
N/A
Biotechnology & Life Sciences
Healthcare
US
Rockville

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App